News

On Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, ...
The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug ...
A production issue raised concerns that ink printing on some cups could run when exposed to high temperatures, inspectors ...
By Stephanie Brown HealthDay ReporterTUESDAY, July 15, 2025 (HealthDay News) -- The U.S Food and Drug Administration has ...
The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.
The FDA cracked down on two plants in India and one in Korea in separate recently released reports, citing issues ranging ...
The FDA approved four drugs last year without any U.S. trial participants, but has maintained a tougher stance on China, even ...
The FDA told Whoop that its Blood Pressure Insights feature (available only on the Whoop MG with the top-tier Life membership ...
After state lawmakers outlawed the fluoridation of communities' waters, a Utah dentist is testifying to the FDA to encourage ...
The warning reflects growing concern over a surge in opioid products marketed to US consumers containing concentrated levels of 7-hydroxymitragynine (7-OH).
The agency claims Whoop is marketing an unauthorized medical device intended to diagnose, cure, treat or prevent a disease.
The U.S. Food and Drug Administration's staff reviewers on Wednesday raised efficacy concerns over Otsuka Pharma's combination treatment for adults with post-traumatic stress disorder (PTSD), citing ...